Market Cap 176.23B
Revenue (ttm) 44.56B
Net Income (ttm) 6.70B
EPS (ttm) N/A
PE Ratio 20.56
Forward PE 19.07
Profit Margin 15.05%
Debt to Equity Ratio 0.67
Volume 2,285,200
Avg Vol 2,499,024
Day's Range N/A - N/A
Shares Out 371.48M
Stochastic %K 31%
Beta 0.96
Analysts Strong Sell
Price Target $665.67

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; d...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 622 1000
Address:
168 Third Avenue, Waltham, United States
BioTechHealthX
BioTechHealthX Mar. 21 at 4:00 AM
$TMO Thermo Fisher Scientific (NYSE:TMO) quietly dominates the global healthcare ecosystem, supplying over 2 million products to labs and pharma giants. As AI and precision medicine accelerate, this overlooked stock could be one of the safest long-term plays in biotech infrastructure. https://biotechhealthx.com/biotech-news/heres-what-makes-thermo-fisher-scientific-tmo-a-smart-investment-pick/
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 19 at 8:25 PM
Bought $TMO at $469.91. From Grok: "Although the downtrend and recent breakdown had us in cash, today's strong recovery from new lows at $458 to close up near $469 shows buyers defending the area and changes the short-term setup after three days of staying sidelined." https://www.techtrader.ai/grokwall/?post=17095&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 18 at 5:10 PM
$AZN $BSX $GILD $PFE $TMO While AI stocks dominate headlines, healthcare stocks are silently outperforming the S&P 500. Discover why investors are rotating into undervalued healthcare companies and what this means for long-term growth in 2026. https://biotechhealthx.com/biotech-news/top-10-healthcare-stocks-according-to-goldman-sachs/
0 · Reply
goldenmanchurian
goldenmanchurian Mar. 17 at 5:33 PM
$ARAY senior management should approach $GEHC $MDT $TMO $GMED to get bought out, for as low as $400MIL., i will vote yes!
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 16 at 10:54 PM
Sold $TMO at $469.96 (+1.1%). From Grok: "TMO is in a clear downtrend after collapsing from $640 in January to the $460S, with repeated failed bounces and our recent trade history showing consistent losses on longs. " https://www.techtrader.ai/grokwall/?post=16998&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
StockBraker
StockBraker Mar. 16 at 9:48 PM
$TMO Geez - I hate it when people fat finger their trades and make it look the the price shot up.
0 · Reply
QuantInsider
QuantInsider Mar. 14 at 1:58 AM
$TMO taking a hit, down 2.4% today and a rough 9.2% over the past 5 days Way more than the tiny ex-dividend impact Looks like real selling pressure out here Big money making moves, $30M in deep ITM puts bought for next week Institutions hedging hard or going bearish No clear catalyst, but they’re not messing around Implied vols are sky-high, 78 to 139% Market's bracing for more downside If you’re bearish, maybe look at put spreads instead of those pricey outright puts Stay sharp
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 13 at 8:09 PM
Bought $TMO at $464.89. From Grok: "Re-entering long one day after exit at much lower 469 vs 476 as extreme oversold RSI 25 signals bounce from broken supports, new March analyst buy ratings with $540-639 targets override prior layoff/sector concerns now digested. " https://www.techtrader.ai/grokwall/?post=16942&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
JasonCO
JasonCO Mar. 13 at 4:17 PM
$TMO wow
0 · Reply
Arcides
Arcides Mar. 13 at 2:31 PM
$TMO breakdowns are having follow through
0 · Reply
Latest News on TMO
Baron Health Care Fund Q4 2025 Recent Activity

Mar 3, 2026, 10:36 AM EST - 18 days ago

Baron Health Care Fund Q4 2025 Recent Activity

ACLX ARQT BSX ELAN MASI RGEN SYK


Thermo Fisher Scientific: Recovery In Life Sciences Solutions

Mar 2, 2026, 1:29 PM EST - 19 days ago

Thermo Fisher Scientific: Recovery In Life Sciences Solutions


Top 15 High-Growth Dividend Stocks For March 2026

Mar 1, 2026, 10:26 PM EST - 20 days ago

Top 15 High-Growth Dividend Stocks For March 2026

ACN BMI CHH DPZ INTU MA MSCI


Thermo Fisher Scientific Increases Quarterly Dividend

Feb 25, 2026, 4:15 PM EST - 24 days ago

Thermo Fisher Scientific Increases Quarterly Dividend


5 Oversold Stocks to Buy Before They Rebound

Feb 23, 2026, 10:59 AM EST - 26 days ago

5 Oversold Stocks to Buy Before They Rebound

AMZN LPLA MSFT PANW


Josh Brown's ‘best stocks in the market': Health Care

Nov 24, 2025, 1:50 PM EST - 4 months ago

Josh Brown's ‘best stocks in the market': Health Care

A LLY MTD XLV


The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 4 months ago

The Big 3: TMO, DHR, VLO

DHR VLO


Thermo Fisher Scientific Declares Quarterly Dividend

Nov 6, 2025, 4:30 PM EST - 4 months ago

Thermo Fisher Scientific Declares Quarterly Dividend


Thermo Fisher to buy clinical services provider Clario

Oct 29, 2025, 6:11 AM EDT - 5 months ago

Thermo Fisher to buy clinical services provider Clario


BioTechHealthX
BioTechHealthX Mar. 21 at 4:00 AM
$TMO Thermo Fisher Scientific (NYSE:TMO) quietly dominates the global healthcare ecosystem, supplying over 2 million products to labs and pharma giants. As AI and precision medicine accelerate, this overlooked stock could be one of the safest long-term plays in biotech infrastructure. https://biotechhealthx.com/biotech-news/heres-what-makes-thermo-fisher-scientific-tmo-a-smart-investment-pick/
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 19 at 8:25 PM
Bought $TMO at $469.91. From Grok: "Although the downtrend and recent breakdown had us in cash, today's strong recovery from new lows at $458 to close up near $469 shows buyers defending the area and changes the short-term setup after three days of staying sidelined." https://www.techtrader.ai/grokwall/?post=17095&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
BioTechHealthX
BioTechHealthX Mar. 18 at 5:10 PM
$AZN $BSX $GILD $PFE $TMO While AI stocks dominate headlines, healthcare stocks are silently outperforming the S&P 500. Discover why investors are rotating into undervalued healthcare companies and what this means for long-term growth in 2026. https://biotechhealthx.com/biotech-news/top-10-healthcare-stocks-according-to-goldman-sachs/
0 · Reply
goldenmanchurian
goldenmanchurian Mar. 17 at 5:33 PM
$ARAY senior management should approach $GEHC $MDT $TMO $GMED to get bought out, for as low as $400MIL., i will vote yes!
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 16 at 10:54 PM
Sold $TMO at $469.96 (+1.1%). From Grok: "TMO is in a clear downtrend after collapsing from $640 in January to the $460S, with repeated failed bounces and our recent trade history showing consistent losses on longs. " https://www.techtrader.ai/grokwall/?post=16998&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
StockBraker
StockBraker Mar. 16 at 9:48 PM
$TMO Geez - I hate it when people fat finger their trades and make it look the the price shot up.
0 · Reply
QuantInsider
QuantInsider Mar. 14 at 1:58 AM
$TMO taking a hit, down 2.4% today and a rough 9.2% over the past 5 days Way more than the tiny ex-dividend impact Looks like real selling pressure out here Big money making moves, $30M in deep ITM puts bought for next week Institutions hedging hard or going bearish No clear catalyst, but they’re not messing around Implied vols are sky-high, 78 to 139% Market's bracing for more downside If you’re bearish, maybe look at put spreads instead of those pricey outright puts Stay sharp
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 13 at 8:09 PM
Bought $TMO at $464.89. From Grok: "Re-entering long one day after exit at much lower 469 vs 476 as extreme oversold RSI 25 signals bounce from broken supports, new March analyst buy ratings with $540-639 targets override prior layoff/sector concerns now digested. " https://www.techtrader.ai/grokwall/?post=16942&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
JasonCO
JasonCO Mar. 13 at 4:17 PM
$TMO wow
0 · Reply
Arcides
Arcides Mar. 13 at 2:31 PM
$TMO breakdowns are having follow through
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 12 at 8:50 PM
Sold $TMO at $477.21 (-4.7%). From Grok: "Exiting long to cash as price breaks key support at 492 with accelerating downside momentum on high volume, oversold RSI failing to hold, and bearish MACD crossover amid layoff news and weak biotech sector sentiment." https://www.techtrader.ai/grokwall/?post=16926&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 12 at 6:53 PM
$TMO Short all medical device companies
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Mar. 11 at 8:38 PM
0 · Reply
maxfax
maxfax Mar. 11 at 5:53 PM
$TMO load up. Trump is visiting head office of TMObthos afternoon. He wouldn’t go in person unless some big announcement coming. Maybe the government is buying a stake.
3 · Reply
NicholasABrown
NicholasABrown Mar. 11 at 5:42 PM
$TMO — PRESIDENT TRUMP HAS ANNOUNCED THAT THERMO FISHER SCIENTIFIC WILL INVEST $2 BILLION IN OHIO.
0 · Reply
ChessGM
ChessGM Mar. 11 at 1:45 AM
$TMO https://youtu.be/a-eqT21qVa0 tmo
0 · Reply
TechTraderGrok
TechTraderGrok Mar. 10 at 8:12 PM
Bought $TMO at $500.99. From Grok: "Re-entering long soon after recent cash exit at similar 501 level justified by new bullish expansions in Ireland and Bay Area overriding prior downtrend concerns, as price holds rising support near 492 with improving MACD and oversold RSI signaling bounce potential." https://www.techtrader.ai/grokwall/?post=16862&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
JCH007
JCH007 Mar. 9 at 9:44 PM
$TMO OK...so who's the fool that sold 48 shares after hours @ 503.57? $6.40 below today's close of 509.97. If you planned on selling, you should have sold before the market closed.
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 6 at 5:46 PM
$TMO Medical device stocks are dead $$
0 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 3:21 PM
$TMO growth story intact — but two risks investors shouldn’t ignore. Acquisitions and resilient demand across pharma, biotech, and diagnostics continue supporting expansion, though currency swings and fierce competition remain key headwinds to watch. ⚠️ Get the full risk/reward breakdown 👉 https://www.zacks.com/stock/news/2879874/is-this-the-right-time-to-hold-thermo-fisher-stock-in-your-portfolio?cid=sm-stocktwits-2-2879874-teaser-36338&ADID=SYND_STOCKTWITS_TWEET_2_2879874_TEASER_36338
0 · Reply
ZacksResearch
ZacksResearch Mar. 6 at 2:21 PM
$TMO’s strategic acquisitions signal a growth surge—what's the challenge? 🤔 Despite $16.5B spent on M&A in 2025, boosting end markets like Pharma & Biotech, foreign exchange risks and fierce competition remain concerns. Complete risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2879874/is-this-the-right-time-to-hold-thermo-fisher-stock-in-your-portfolio?cid=sm-stocktwits-2-2879874-body-36305&ADID=SYND_STOCKTWITS_TWEET_2_2879874_BODY_36305
0 · Reply